Shanghai Beinuo Biotechnology Co., Ltd. was established in2007year,It was jointly founded by biomedical experts studying in the United States and domestic life science experts, with technical support and theoretical guidance provided by life science research experts such as the Institute of Health Sciences, Chinese Academy of Sciences, Shanghai Institute of Immunology, Shanghai Institute of Endocrinology, Shanghai Institute of Hematology, Shanghai Jiao Tong University, and Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine.

Beinuo Biotechnology selects products from brands and domestic certified suppliers with reliable quality and quality system management, and can provide a product portfolio based on immunology, molecular biology, cell biology, and microbiology according to the needs of the project. By combining imported products with domestically selected and reliable product combinations, we ensure that your project can be completed smoothly and even with high quality.

If Beinuo Biotechnology does not have the product you need to purchase, we will also recommend high-quality suppliers for you to choose and refer to on your own. Beinuo Biotechnology is a professional provider of comprehensive scientific research reagent services. Bringing together renowned reagent suppliers with strict quality control systems and experienced academic personnel in the field of biology, we are committed to providing * consultation and guidance on biological reagents for Chinese medical and biological research, saving your experimental time and funds, and safeguarding your paper publication!

The initial goal of the company is to establish a fast supply system for domestic life science research. We are building a fully equipped life science research reagent spot supply center to serve the rapid development of life science research. The ultimate goal of company ZCreating competitive independent intellectual property brand products in the fields of life sciences and medical science researchStrive to break the monopoly of European and American biotechnology companies in the field of life sciences, promote the industrialization of life science research in China, and contribute to the development of life sciences in China.